Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Single-arm, Multicenter Exploratory Clinical Study of the Combination of Etoposide, Cytarabine and PEG-rhG-CSF (EAP Regimen) on Hematopoietic Stem Cell Mobilization in Poor Mobilization Patients With Hematological Malignancies

NCT05510089 is registered in ClinicalTrials.gov with The Affiliated People's Hospital of Ningbo University as lead sponsor.

NCT NCT05510089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05510089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Single-arm, Multicenter Exploratory Clinical Study of the Combination of Etoposide, Cytarabine and PEG-rhG-CSF (EAP Regimen) on Hematopoietic Stem Cell Mobilization in Poor Mobilization Patients With Hematological Malignancies
Lead sponsor
The Affiliated People's Hospital of Ningbo University
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2022
Completion date
December 31, 2024
Enrollment
62 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancy